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1Arkana Laboratories, Little Rock, Arkansas, USAIntroduction: Ig deposits identiﬁed on renal biopsy samples by parafﬁn immunoﬂuorescence that show
negative staining by routine immunoﬂuorescence on frozen tissue have become known as “masked”
deposits. Membranous-like glomerulopathy with masked IgG kappa (k) deposits is a recently recognized
pattern of immune complex deposition characterized by masked deposits that show IgG k restriction and
are subepithelial and mesangial by electron microscopy. Based on the frequent presence of C3-only
staining by routine immunoﬂuorescence microscopy (IF), these cases could be misdiagnosed as C3
glomerulonephritis in the absence of parafﬁn immunoﬂuorescence evaluation.
Methods: The clinicopathologic details of all cases of membranous-like glomerulopathy with masked IgG
k deposits diagnosed in our laboratory were included, beginning with the initial recognition of this entity in
2011 through the end of 2015. Inclusion was based on renal biopsy sample morphologic features including
glomerular deposits that stain for IgG k and have a staining intensity that is signiﬁcantly brighter by
parafﬁn IF than by routine IF on frozen tissue.
Results: This pattern of immune complex deposition has been seen in 41 patients in our laboratory over a
5-year period. The patients with these biopsy ﬁndings are most commonly young female individuals with a
mean age of 27.5 years, with 88% being less than 40 years. All patients had proteinuria with a mean
24-hour urine protein of 3.5 g (range 0.512.8 years) and 35% with nephrotic-range proteinuria. Hematuria
was present in 88% of patients, and 29% had elevated serum creatinine at presentation. Autoimmune
serologic tests were positive in 55% of patients, with a weakly positive antinuclear antibody being most
common. Despite this, only 1 patient (2%) fulﬁlled the diagnostic criteria for systemic lupus erythemato-
sus. The outcome data were mixed, as some patients showed spontaneous remission and mild disease
whereas others progressed to end-stage renal disease. There was no apparent correlation between the
treatment used and outcome in this retrospective analysis. One patient underwent transplantation and
developed biopsy-proven recurrence of disease in the graft 42 months posttransplantation. The etiology of
this entity remains unknown.
Discussion: We provide an expanded case series detailing the clinicopathologic ﬁndings of patients with
membranous-like glomerulopathy with masked IgG k deposits. Patients are most commonly young female
individuals <40 years of age and commonly have positive autoimmune serologic studies such as anti-
nuclear antibody, although few carry a diagnosis of any well-deﬁned autoimmune disease such as lupus.
The outcome data were mixed, as some patients showed spontaneous remission and mild disease
whereas others progressed to ESRD. There was no apparent correlation between the treatment used and
outcome in this retrospective analysis.
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International Reports (2016) 1, 299–305history. In most cases of glomerulonephritis, the renal
biopsy diagnosis rendered is a morphologic pattern of
injury rather than a speciﬁc disease. Careful clinico-
pathologic correlation and often extensive serologic
testing are necessary to determine the speciﬁc under-
lying etiologic disease state. A good example is the
renal biopsy diagnosis of membranous glomerulopathy,
an immune complexmediated glomerulopathy in299
CLINICAL RESEARCH CP Larsen et al.: Membranous-Like Glomerulopathywhich the immune deposits are predominantly sub-
epithelial and IgG is the principal Ig. This disease may
be primary or secondary. Secondary associations are a
broad and diverse group that includes drugs, malig-
nancy, infection, and autoimmune disease, among
others.1,2 The renal biopsy diagnosis of membranous
glomerulopathy provides a framework for the workup
that should be initiated and also has prognostic and
treatment implications. In addition, it clusters the pa-
tients into meaningful groups that can be further
studied, enabling breakthroughs in our understanding
of the underlying disease such as the recent recog-
nition of PLA2R and THSD7A autoantibodies as the
etiology of most cases of primary membranous
glomerulopathy.3,4
In 2014, we reported 14 cases of an immune
complexmediated form of glomerulopathy with a
unique pattern of immune deposition that was termed
“membranous-like glomerulopathy with masked IgG
kappa deposits” (MGMID).5 The renal biopsy ﬁndings
were distinctive in that the deposits showed false-
negative staining for Igs by routine immunoﬂuores-
cence, with strong staining for IgG and kappa (k) (but
not lambda [l]) by parafﬁn immunoﬂuorescence. The
deposits were subepithelial and/or mesangial by elec-
tron microscopy. The entity was also characterized by
unique clinical ﬁndings compared to other glomerular
diseases with monoclonal deposits, in that the patients
affected were relatively young female individuals who
often had some evidence of autoimmune disease.6,7
Here, we expand this cohort to describe the clinico-
pathologic ﬁndings in 41 patients with MGMID, with
follow-up data also presented.
MATERIALS AND METHODS
All cases were processed by light, immunoﬂuorescence,
and electron microscopy using routine techniques.8
Brieﬂy, kidney biopsy samples were ﬁxed in buffered
formalin, dehydrated in graded alcohols, and
embedded in parafﬁn using standard techniques. Serial
3-mm-thick sections were cut and treated with hema-
toxylin and eosin, Jones methenamine silver, Masson
trichrome, and periodic acidSchiff reagent. All data
were collected according to protocols approved by
Schulman Institutional Review Board.
Immunoﬂuorescence
Samples were transported in Michel’s media, washed in
buffer, and frozen in a cryostat. Sections, cut at 5 mm,
were rinsed in buffer and reacted with ﬂuorescein-
tagged polyclonal rabbit anti-human antibodies to
IgG, IgA, IgM, C3, C4, C1q, ﬁbrinogen, and k-, and
l-light chains (all from Dako, Carpenteria, CA) for 1
hour, rinsed, and a coverslip applied using aqueous300mounting media. IgA, IgG, IgM, k, and l were detected
in parafﬁn-embedded sections using ﬂuorescein-tagged
polyclonal rabbit anti-human antibodies (all from Dako,
Carpenteria, CA). The stains were evaluated by stan-
dard immunoﬂuorescence microscopy using a Leica L5
ﬁlter cube and scored on a scale of 0 to 3. PLA2R was
performed on parafﬁn-embedded sections following
protease digestion using rabbit polyclonal anti-PLA2R
antibodies (Sigma-Aldrich, St. Louis, MO) at a dilu-
tion of 1:50, followed by highly cross-adsorbed Alexa
Fluor 488 goat anti-rabbit IgG (Life Technologies,
Carlsbad, CA) at a dilution of 1:100 as previously
described.2 Immunoperoxidase staining for THSD7A
was performed in parafﬁn-embedded sections using
rabbit polyclonal anti-THSD7A antibodies (Sigma-
Aldrich, St. Louis, MO) at a dilution of 1:800, as pre-
viously described.9
Parafﬁn immunoﬂuorescence was performed as
described elsewhere.7,10 Brieﬂy, sections were cut at
3 mm and deparafﬁnized in xylene, followed by alcohol
gradient, and proteinase K (Dako, Carpenteria, CA) was
applied for 30 minutes at room temperature. The sec-
tions were then rinsed in buffer and reacted with
ﬂuorescein-tagged polyclonal rabbit anti-human anti-
bodies to IgG, IgA, IgM, k-, and l-light chains (all from
Dako, Carpenteria, CA) at room temperature, rinsed,
and a coverslip applied using aqueous mounting media.
Electron Microscopy
The ends of the renal biopsy specimen were removed as
1-mm cubes, dehydrated using graded alcohols, and
embedded in epon/araldite resin. Sections 1-mm thick
were cut using an ultramicrotome, stained with tolui-
dine blue, and examined with a light microscope. Thin
sections were examined in a Jeol JEM-1011 or a Jeol
1400 electron microscope (Jeol, Tokyo, Japan). “Hump-
like” deposits were deﬁned as large deposits with a
rounded conﬁguration present on the surface of the
glomerular basement membrane, with minimal associ-
ated basement membrane response. In general, these
deposits are as high above the glomerular basement
membrane as they are wide along its surface. Hinge
deposits were deﬁned as hump-like deposits overlying
the mesangium between folds of glomerular basement
membrane.
Clinical Deﬁnitions
Hematuria was deﬁned as >5 red blood cells per high-
power ﬁeld on microscopic examination of urine sedi-
ment. Nephrotic syndrome was deﬁned as 24-hour
urine protein > 3.5 g/d, hypoalbuminemia (<3.5
g/dl), and peripheral edema. Elevated serum creatinine
was deﬁned as a serum creatinine > 1.2 mg/dl. The
following deﬁnitions were applied for the purposes ofKidney International Reports (2016) 1, 299–305
Table 1. Clinical characteristics of patients with membranous-like
glomerulopathy with masked IgG k deposits
Characteristic Value
Mean age, yr (range) 27.5 (1073)
#40, n (%) 36 (88%)
4055, n (%) 3 (7%)
>55, n (%) 2 (5%)
Female/male, n (%) 32 (78%)/9 (22%)
Race/ethnicity
White, n (%) 26 (63%)
Hispanic, n (%) 9 (22%)
African American, n (%) 3 (7%)
Other, n (%) 3 (7%)
Mean serum Cr at biopsy, mg/dl (range) 1.4 (0.56.4)
Elevated serum Cr at presentation, n (%) 12 (29%)
Mean quantitative urine protein, g/24 h (range) 3.5 (0.512.8)
Proteinuria < 1 g/24 h, n (%) 4/40 (10%)
Proteinuria 13.5 g/24 h, n (%) 22/40 (55%)
Proteinuria > 3.5 g/24 h, n (%) 14/40 (35%)
Hematuria, n (%) 35/40 (88%)
Positive autoimmune serologic test, n (%) 22/40 (55%)
Positive ANA, n (%) 20/38 (53%)
Positive dsDNA, n (%) 9/39 (23%)
Positive ANA and dsDNA, n (%) 8/40 (20%)
Normal C3 and C4, n (%) 33/38 (87%)
Fulﬁlls diagnostic criteria for SLE, n (%) 1/41 (2%)
ANA, antinuclear antibody; SLE, systemic lupus erythematosus.
CP Larsen et al.: Membranous-Like Glomerulopathy CLINICAL RESEARCHoutcome analysis and are similar to those used by Nasr
et al.6: complete remission, remission of proteinuria
to <500 mg/d with normal renal function; partial
remission, reduction in proteinuria by $50% and
to <2 g/d with stable renal function (no more than a
20% increase in serum Cr); persistent kidney
dysfunction, failure to meet criteria for complete or
partial remission but not reaching end-stage kidney
disease (incudes patients with unremitting proteinuria
or progressive chronic kidney disease); and end-stage
kidney disease, requiring renal replacement therapy.
RESULTS
Clinical Features
All cases of MGMID diagnosed in our laboratory were
included, beginning with the initial recognition of this
entity in 2011 through the end of 2015. Inclusion was
based on renal biopsy sample morphologic features,
including glomerular deposits that stain for IgG k and
have a staining intensity that is signiﬁcantly brighter
by parafﬁn IF than by routine IF on frozen tissue. By
electron microscopy, the deposits must be predomi-
nantly subepithelial and/or mesangial. Cases with a
membranoproliferative pattern by light microscopy
were excluded. There were 41 patients out of 42,711
total kidney biopsy samples (0.1%) processed during
this 5-year study period (including 14 cases that were
previously published5).
The patients were commonly young, with 88%
being <40 years of age (Table 1), although there were 2
elderly patients (70 and 73 years). The youngest patient
was 10 years of age. Females were affected more than
males, with a ratio of 3.6 to 1. Cases were identiﬁed in
multiple ethnicities, although individuals of white
ethnicity were most common at 63%. Proteinuria was
the indication for biopsy in 36 of 41 patients (88%), and
the mean proteinuria was 3.5 g/d. In all, 14 of 40 patients
(35%) with known quantitative proteinuria at the time
of biopsy had proteinuria in the nephrotic range (>3.5 g/
day). Of the 40 patients, 35 (85%) had hematuria.
Positive autoimmune serologic test results were
common, with 55% of patients showing some positivity
(Table 1). The most frequent positive serologic tests
were antinuclear antibody (ANA) (53%) and dsDNA
(23%). Two of 17 patients tested for anti-neutrophil
cytoplasmic antibody (ANCA) were positive (12%), but
all 7 cases with crescent formation were negative for
ANCA. Two of 23 cases tested for rheumatoid factorwere
positive (9%). Thirty-seven cases were tested for hepa-
titis B and hepatitis C, and all were negative. Most pa-
tients showed normal C3 and C4 (87%), although there
were 5 cases with hypocomplementemia including 1
case with low C3, 2 cases with low C4, and 2 cases withKidney International Reports (2016) 1, 299–305low C3 and C4. Serum protein electrophoresis was
negative for paraproteins in 25 of 26 patients tested
(96%). One patient, a 55-year-old man, had a small M-
spike on serum protein electrophoresis but no evidence
of a hematopoietic malignancy on further evaluation.
Pathologic Findings
Light Microscopy
Biopsy samples undergoing light microscopy had a
mean of 18.8 glomeruli (range 847) with a mean of 4.3
(mean 23%) globally sclerotic. Approximately 50% of
the cases had normocellular glomeruli by light micro-
scopy, with the remaining 50% showing mesangial
hypercellularity, focal segmental glomerulosclerosis, or
focal/diffuse crescentic glomerulonephritis (Table 2,
Figure 1). At least segmental glomerular basement
membrane “spikes” and/or “holes” were present in
most cases. There were no cases with endocapillary
proliferation or a membranoproliferative pattern. No
wire loops or hyaline thrombi were present in any case.
Most of the cases (73%) showed no to mild interstitial
ﬁbrosis. None of the cases had morphologic evidence of
a second underlying kidney disease. No cases showed
evidence of acute or chronic thrombotic micro-
angiopathy, and there was no evidence of arteritis.
Immunoﬂuorescence Microscopy
The most common antibody positive by routine, frozen
immunoﬂuorescence microscopy (IF) was C3, which
was present in 32 cases (78%), with a mean intensity of301
Table 2. Light microscopy results
Finding Value
Total number of glomeruli, mean n (range) 18.8 (847)
Number of globally sclerotic glomeruli, mean n (%) 4.3 (23%)
Predominant glomerular pattern
Normal, n (%) 20 (49%)
Mesangial hypercellularity, n (%) 8 (20%)
FSGS, n (%) 6 (15%)
Crescentic/focal crescentic, n (%) 7 (17%)
Focal, n (%) 4 (10%)
Diffuse, n (%) 3 (7%)
Interstitial ﬁbrosis
None, n (%) 18 (44%)
Mild, n (%) 12 (29%)
Moderate, n (%) 6 (15%)
Severe, n (%) 5 (12%)
FSGS, focal segmental glomerulosclerosis.
CLINICAL RESEARCH CP Larsen et al.: Membranous-Like Glomerulopathy2þ (Table 3). A total of 28 cases (68%) had C3
intensity $2 orders of magnitude more than any other
immune reactant or were C3 only (scale of 03) and
therefore could have been misclassiﬁed as C3 glomer-
ulonephritis. Twelve cases (29%) had staining for Ig by
frozen IF that had a mean intensity of #1þ. This
included 6 cases (15%) with 1þ IgG staining by frozen
IF. Five of these 6 with IgG staining had C3 predomi-
nance by frozen IF. IgG subclass staining was per-
formed in each of these cases, and all showed
exclusively IgG1-only staining (negative for IgG2,
IgG3, and IgG4). The parafﬁn IF showed a similar
staining pattern for all antibodies except IgG and k.
These were strongly positive in all cases (mean in-
tensity 2.9þ). The deposits were diffuse (present in
more than half of glomeruli) in all cases. Mesangial
staining was present in all cases. There was segmental
(<50% loop involvement) staining of the capillary
loops in 13 cases (32%) and global (>50% loop
involvement) staining in 27 (68%). However, these
cases with a global pattern had incomplete involvement
of capillary loops in virtually all cases. PLA2R and
THSD7A stains were performed and were negative in
all cases tested (29 and 5 cases, respectively).
Electron Microscopy
Electron microscopy was available for all 41 cases.
Almost all cases showed evidence of subepithelial and
mesangial deposits (Table 4). There was 1 case of an
18-year-old girl with numerous mesangial-only deposits
that showed 3þ C3 staining without Igs by frozen IF
and, by parafﬁn IF, there was intense IgG and k
staining. Two cases had subepithelial deposits without
mesangial deposition. Subendothelial deposits were
identiﬁed in 3 cases but were rare, when present. There
were 30 cases (73%) that had either hump-like and/or
hinge region deposits, including 6 cases with only
hump-like deposits, 6 cases with only hinge-region
deposits, and 18 cases with both.302Treatment and Clinical Outcome
Follow-up was available in 27 patients for a mean of 22
months (range 6-51 months). These patients were
treated with a variety of regimens (Table 5). The out-
comes were mixed, with 15 patients undergoing com-
plete or partial remission and 12 patients who had
persistent disease on follow-up or progressed to ESRD
(Table 6). There was no correlation between the treat-
ment used and the clinical outcome. One of the patients
who progressed to ESRD underwent renal trans-
plantation and had biopsy-proven recurrence of disease
in the graft 42 months after transplantation. The indi-
cation for the transplant biopsy was proteinuria. The
biopsy from the transplant had a membranous pattern
of immune complex deposition. The deposits were
masked in both the native and allograft biopsy,
showing negative staining for all immune reactants by
routine immunoﬂuorescence and strong staining for
IgG and k by parafﬁn IF.DISCUSSION
Most renal pathology laboratories in the United
States perform evaluation for the presence of immune
deposits using direct immunoﬂuorescence on frozen
unﬁxed tissue. “Masked deposits” refer to Igs that
show false-negative staining by routine frozen
immunoﬂuorescence but that can be detected when
immunoﬂuorescence is repeated on formalin-ﬁxed,
parafﬁn-embedded tissue. Parafﬁn immunoﬂuores-
cence is a valuable technique for the detection of Igs in
renal biopsy samples, which has largely been used as
a salvage technique when inadequate tissue was avail-
able to perform the testing on frozen unﬁxed tissue.1114
However, the study by Nasr et al.11 includes the ﬁrst
description of masked deposits revealed by this tech-
nique. Speciﬁcally, the authors found 10 cases of crys-
talline light chain proximal tubulopathy that all had
staining for light chains by parafﬁn IF but only 4
of 10 with positive staining by routine IF. This phe-
nomenon of masked light chain crystals in proximal
tubulopathy has been conﬁrmed in multiple subsequent
papers and is now well established.15,16 The initial
description ofMGMID5was theﬁrst report ofmasked Igs
in the glomeruli.5 Other glomerulonephritides subse-
quently described to show masked deposits include
membranoproliferative glomerulonephritiswithmasked
monotypic Ig deposits7 and cryoglobulinemic glomeru-
lonephritis.10 The entities with masked deposits
described thus far are heterogeneous both clinically
and pathologically. However, the common feature in
these disparate entities is the presence of a monotypic Ig
molecule, raising the possibility that this plays an
important role in the disease.Kidney International Reports (2016) 1, 299–305
Figure 1. Renal biopsy ﬁndings in membranous-like glomerulopathy with masked IgG k deposits. (a) Segmental “spikes” and “holes” are present
along the glomerular basement membranes by Jones methenamine silver stain (original magniﬁcation 400). (b) Electron microscopy reveals
numerous large subepithelial deposits present along the glomerular basement membrane (unstained, original magniﬁcation12,000). (c) Glomeruli
stain negative for IgG by routine immunoﬂuorescence on fresh tissue. (d) Glomeruli from the same case stain positive on parafﬁn-embedded tissue
after protease digestion (direct immunoﬂuorescence; original magniﬁcation400). (e) Glomeruli show staining for k and (f) not l on the protease-
digested, parafﬁn-embedded tissue (direct immunoﬂuorescence; original magniﬁcation 400).
CP Larsen et al.: Membranous-Like Glomerulopathy CLINICAL RESEARCHMGMID is unique in many ways but also has clin-
icopathologic features in common with other forms of
glomerulonephritis. These similarities and differencesKidney International Reports (2016) 1, 299–305with other diseases that have known underlying eti-
ologies allow speculation as to the etiology of MGMID.
The deposits are subepithelial and mesangial in almost303
Table 5. Treatments used in patients with MGMID
Treatment
No. of patients (% of patients),
n [ 27
None 6 (22%)
RAS blockade alone 6 (22%)
Steroids and calcineurin inhibitor 4 (15%)
Steroids and mycophenolate 7 (26%)
Steroids and plaquenil 1 (4%)
Steroids, calcineurin inhibitor, and rituximab 1 (4%)
Steroids and azathioprine 1 (4%)
Rituximab alone 1 (4%)
MGMID, membranous-like glomerulopathy with masked IgG k deposits; RAS,
reninangiotensin system.
Table 3. Immunoﬂuorescence results
Antibody
Immunoﬂuorescence, frozena
% positive (mean intensity
among positive)
Immunoﬂuorescence, parafﬁna
% positive (mean intensity
among positive)
IgA 5% (1þ) 5% (1þ)
IgM 17% (0.9þ) 22% (0.9þ)
IgG 15% (0.8þ) 100% (2.9þ)
C3 78% (2þ) NA
Kappa (k) 17% (1þ) 100% (2.9þ)
Lambda (l) 10% (1þ) 12% (1þ)
PLA2R (n ¼ 29) NA 0
THSD7A (n ¼ 5) NA 0
aScale 0, trace, 1þ, 2þ, 3þ.
CLINICAL RESEARCH CP Larsen et al.: Membranous-Like Glomerulopathyall cases, and the granular staining pattern that is
present by parafﬁn IF is diffuse; however, unlike
PLA2R- or THSD7A-associated membranous glomerul-
opathy, it typically shows incomplete involvement of
the glomerular capillary walls. This suggests that the
Igs depositing in the glomeruli are more likely to be
circulating immune complexes trapped in the sub-
epithelial space than in situ immune complex formation
directed against a podocyte antigen. The presence of
mesangial deposits and the frequent ﬁnding of large
hump-like deposits also support this hypothesis. The
latter are most classically associated with trapping of
circulating immune complexes in the setting of infec-
tion17 but have also been described in experimental
models of serum sickness.18 The positive serologic
studies such as ANA in many of the patients suggest
the presence of some immune dysregulation such as an
underlying autoimmune process. The light chain re-
striction in glomerular deposits is unusual, but is not
necessarily indicative of an underlying hematologic
aberrancy, as other forms of glomerulonephritis with
this change commonly do not show associated dis-
ease.6,19 It is also possible that the immune response
underlying this disease is actually polyclonal but that
only the IgG molecules with k light chains have the
physiochemical qualities that lead to trapping and
deposition in the glomeruli. Therefore, based on what
we know of MGMID and other diseases with more
well-deﬁned etiologies, we hypothesize that this dis-
ease is driven by glomerular deposition of circulating
immune complexes in which the IgG k molecules
possess the appropriate properties to become trappedTable 4. Electron microscopy results
Electron microscopy ﬁnding
No. of cases (% of cases),
n [ 41
Subepithelial deposits 40 (98%)
Mesangial deposits 39 (95%)
Subendothelial deposits 3 (10%)
Subepithelial “humps” 24 (59%)
Hinge-region deposits 24 (59%)
304in the glomeruli. We are currently collecting the bio-
specimens necessary to further investigate this
possibility.
The discovery of new diagnostic entities provides a
subclassiﬁcation of patients thought to have a common
underlying pathogenesis. These attempts usually prove
to be imperfect until the underlying etiology of disease
is discovered. Prior to this, separating out disease cat-
egories based on shared clinical and morphologic
parameters enables guidance for treatment, prognosti-
cation, and the ability to perform the studies necessary
to identify the true pathogenesis. MGMID is at the
early stage of disease classiﬁcation, and, currently, the
diagnostic features of this disease used as inclusion
criteria are based solely on renal biopsy morphologic
ﬁndings. Clearly, this is an imperfect system that
brings up obvious questions. For example, should
masking really be required for diagnosis? What about
cases with masked l restriction? Nevertheless, we have
found that patients who have biopsy samples with the
ﬁndings described as MGMID share common clinical
features. They tend to be young female individuals,
and frequently have nonspeciﬁc positive serologic test
results indicating some role for autoimmune disease;
and, perhaps the most curious aspect of this disease,
the biopsy samples show monotypic Ig deposition
despite the young age and absence of underlying
hematologic neoplasia. We believe that the presence of
these commonalities strengthens the possibility
that patients with these biopsy ﬁndings share a
common molecular pathogenic mechanism of their
disease. We are at the advent of precision medicineTable 6. Clinical outcome by treatment
Treatment
Complete
Remission
Partial
remission
Persistent
disease ESRD
None (n ¼ 3) 1 2 0 0
RAS blockade alone (n ¼ 6) 3 0 3 0
Immunosuppression (n ¼ 15) 7 2 6 0
None; ESRD on presentation
(n ¼ 3)
0 0 0 3
ESRD, end-stage renal disease; RAS, reninangiotensin system.
Kidney International Reports (2016) 1, 299–305
CP Larsen et al.: Membranous-Like Glomerulopathy CLINICAL RESEARCHwith unprecedented tools available to study these
pathogenic processes on a molecular level. When the
underlying etiology of this disease is discovered, the
diagnostic features and nomenclature that we have
described will likely be replaced by terminology and
diagnostic assays that more speciﬁcally deﬁne the dis-
ease. In this regard, we view the current classiﬁcation
criteria for this disease as a bridge to move cases that
were formerly diagnosed as numerous disparate (and
often incorrect) categories into a common pool that can
be further studied in an effort to understand the
pathogenic mechanisms of disease.
In summary, we provide an expanded case series
detailing the clinicopathologic ﬁndings of patients with
MGMID. This entity is newly recognized as a result of
the more frequent use of parafﬁn IF in the renal pa-
thology laboratory in recent years.10,11 Based on the
frequent presence of C3-only staining by routine IF,
many cases would likely have been misplaced in the
category of either C3 glomerulonephritis or infection-
associated glomerulonephritis in the past. Diagnosis
of MGMID is based on renal biopsy ﬁndings of sub-
epithelial and/or mesangial deposits that stain for IgG k
and show signiﬁcantly brighter staining by parafﬁn IF.
We recommend performing parafﬁn IF to evaluate for
the presence of this form of glomerulonephritis in cases
that show mesangial and/or subepithelial deposits
by electron microscopy with little to no Ig staining by
routine IF and a lack of endocapillary proliferation
by light microscopy. The patients are most commonly
young female individuals <40 years of age with posi-
tive autoimmune serologic study results such as ANA,
although a few carry a diagnosis of any well-deﬁned
autoimmune disease such as lupus. The outcome data
were mixed, as some patients showed spontaneous
remission and mild disease, whereas others progressed
to ESRD. There was no apparent correlation between
the treatment used and outcome in this retrospective
analysis. Additional studies are needed to further
deﬁne the etiology and ideal treatment regimen for this
disease.
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